Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Analysis 1.7. Comparison 1 Dihydroartemisinin-piperaquine vs Artesunate plus mefloquine, Outcome 7 P.<br />
vivax parasitaemia.<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 1 Dihydroartemisinin-piperaquine vs Artesunate plus mefloquine<br />
Outcome: 7 P. vivax parasitaemia<br />
Study or subgroup DHA-P AS+MQ Risk Ratio Risk Ratio<br />
1 Mixed P. falciparum and vivax infection at baseline<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Ashley 2003b THA 13/179 19/176 0.67 [ 0.34, 1.32 ]<br />
Smithuis 2004 MMR 40/327 47/325 0.85 [ 0.57, 1.25 ]<br />
Ashley 2004 THA 31/333 16/166 0.97 [ 0.54, 1.71 ]<br />
Mayxay 2004 LAO 0/110 0/110 0.0 [ 0.0, 0.0 ]<br />
Grande 2005 PER 0/262 0/260 0.0 [ 0.0, 0.0 ]<br />
Subtotal (95% CI) 1211 1037 0.84 [ 0.63, 1.12 ]<br />
Total events: 84 (DHA-P), 82 (AS+MQ)<br />
Heterogeneity: Chi 2 = 0.65, df = 2 (P = 0.72); I 2 =0.0%<br />
Test <strong>for</strong> overall effect: Z = 1.19 (P = 0.23)<br />
2 Total P. vivax parasitaemia by day 28<br />
Janssens 2003 KHM 3/195 0/207 7.43 [ 0.39, 142.89 ]<br />
Subtotal (95% CI) 195 207 7.43 [ 0.39, 142.89 ]<br />
Total events: 3 (DHA-P), 0 (AS+MQ)<br />
Heterogeneity: not applicable<br />
Test <strong>for</strong> overall effect: Z = 1.33 (P = 0.18)<br />
3 Total P. vivax parasitaemia by day 42<br />
Janssens 2003 KHM 10/195 9/207 1.18 [ 0.49, 2.84 ]<br />
Smithuis 2004 MMR 40/319 57/316 0.70 [ 0.48, 1.01 ]<br />
Mayxay 2004 LAO 3/106 1/108 3.06 [ 0.32, 28.92 ]<br />
Subtotal (95% CI) 620 631 0.79 [ 0.57, 1.11 ]<br />
Total events: 53 (DHA-P), 67 (AS+MQ)<br />
Heterogeneity: Chi 2 = 2.65, df = 2 (P = 0.27); I 2 =24%<br />
Test <strong>for</strong> overall effect: Z = 1.35 (P = 0.18)<br />
4 Total P. vivax parasitaemia by day 63<br />
Janssens 2003 KHM 39/195 47/207 0.88 [ 0.60, 1.28 ]<br />
Ashley 2003b THA 52/156 42/152 1.21 [ 0.86, 1.69 ]<br />
Ashley 2004 THA 89/319 38/166 1.22 [ 0.88, 1.70 ]<br />
<strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria (Review)<br />
Copyright © 2009 <strong>The</strong> <strong>Cochrane</strong> Collaboration. Published by John Wiley & Sons, Ltd.<br />
0.01 0.1 1 10 100<br />
Favours DHA-P Favours AS+MQ<br />
(Continued ...)<br />
127